Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3572 | 1879 | 44.4 | 88% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
151 | 22214 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DNA VACCINE | Author keyword | 66 | 18% | 18% | 339 |
2 | DNA VACCINES | Author keyword | 42 | 29% | 7% | 124 |
3 | DNA IMMUNIZATION | Author keyword | 35 | 34% | 4% | 83 |
4 | DNA VACCINATION | Author keyword | 28 | 25% | 5% | 97 |
5 | GENETIC IMMUNIZATION | Author keyword | 24 | 41% | 3% | 47 |
6 | GENE GUN | Author keyword | 13 | 24% | 3% | 47 |
7 | GENETIC VACCINATION | Author keyword | 11 | 52% | 1% | 15 |
8 | STELLAR CHANCE 505 | Address | 10 | 73% | 0% | 8 |
9 | DNA INOCULATION | Author keyword | 8 | 75% | 0% | 6 |
10 | GENETIC ADJUVANTS | Author keyword | 7 | 67% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DNA VACCINE | 66 | 18% | 18% | 339 | Search DNA+VACCINE | Search DNA+VACCINE |
2 | DNA VACCINES | 42 | 29% | 7% | 124 | Search DNA+VACCINES | Search DNA+VACCINES |
3 | DNA IMMUNIZATION | 35 | 34% | 4% | 83 | Search DNA+IMMUNIZATION | Search DNA+IMMUNIZATION |
4 | DNA VACCINATION | 28 | 25% | 5% | 97 | Search DNA+VACCINATION | Search DNA+VACCINATION |
5 | GENETIC IMMUNIZATION | 24 | 41% | 3% | 47 | Search GENETIC+IMMUNIZATION | Search GENETIC+IMMUNIZATION |
6 | GENE GUN | 13 | 24% | 3% | 47 | Search GENE+GUN | Search GENE+GUN |
7 | GENETIC VACCINATION | 11 | 52% | 1% | 15 | Search GENETIC+VACCINATION | Search GENETIC+VACCINATION |
8 | DNA INOCULATION | 8 | 75% | 0% | 6 | Search DNA+INOCULATION | Search DNA+INOCULATION |
9 | GENETIC ADJUVANTS | 7 | 67% | 0% | 6 | Search GENETIC+ADJUVANTS | Search GENETIC+ADJUVANTS |
10 | GENETIC VACCINES | 6 | 47% | 0% | 9 | Search GENETIC+VACCINES | Search GENETIC+VACCINES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIRECT GENE TRANSFER | 74 | 34% | 10% | 181 |
2 | MUSCLE INVIVO | 35 | 46% | 3% | 58 |
3 | MEDIATED IMMUNIZATION | 34 | 54% | 2% | 44 |
4 | NUCLEIC ACID IMMUNIZATION | 33 | 71% | 1% | 27 |
5 | GENETIC IMMUNIZATION | 33 | 26% | 6% | 108 |
6 | INTRADERMAL GENE IMMUNIZATION | 25 | 54% | 2% | 32 |
7 | IGE ANTIBODY FORMATION | 18 | 61% | 1% | 19 |
8 | COSTIMULATORY MOLECULE GENES | 18 | 83% | 1% | 10 |
9 | GENE GUN | 18 | 38% | 2% | 37 |
10 | NUCLEIC ACID VACCINES | 16 | 56% | 1% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
DNA vaccines: Immunology, application, and optimization | 2000 | 809 | 234 | 53% |
DNA vaccines: ready for prime time? | 2008 | 300 | 148 | 46% |
Technologies for enhanced efficacy of DNA vaccines | 2012 | 71 | 199 | 43% |
DNA vaccines: Progress and challenges | 2005 | 239 | 72 | 60% |
DNA vaccines | 1997 | 930 | 100 | 62% |
DNA vaccines: an historical perspective and view to the future | 2011 | 118 | 186 | 45% |
DNA vaccines: a review | 2003 | 160 | 38 | 74% |
Electroporation delivery of DNA vaccines: prospects for success | 2011 | 90 | 63 | 46% |
Human clinical trials of plasmid DNA vaccines | 2005 | 96 | 73 | 70% |
Synthetic DNA vaccines: improved vaccine potency by electroporation anc co-delivered genetic adjuvants | 2013 | 21 | 129 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STELLAR CHANCE 505 | 10 | 73% | 0.4% | 8 |
2 | VET INFECT DIS ORG | 3 | 16% | 1.0% | 18 |
3 | STELLAR CHANCE S 505 | 3 | 29% | 0.4% | 8 |
4 | CLIN UNIT ALLERGOL | 2 | 28% | 0.4% | 7 |
5 | BONE MARROW DONOR PROGRAM | 2 | 67% | 0.1% | 2 |
6 | EUROCINE VACCINES AB | 2 | 67% | 0.1% | 2 |
7 | KILGUSS | 2 | 67% | 0.1% | 2 |
8 | RETROVIROL IMMUNOL | 2 | 67% | 0.1% | 2 |
9 | MOL PATHOL EXPT ONCOL | 1 | 38% | 0.2% | 3 |
10 | MED PATHOL 55 LAKE AVE N | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000154616 | MRNA DELIVERY//MRNA TRANSFECTION//RIBOL |
2 | 0.0000092477 | CPG ODN//CPG MOTIF//CPG DNA |
3 | 0.0000088295 | HYDRODYNAMICS BASED PROCEDURE//HYDRODYNAMICS BASED TRANSFECTION//HYDRODYNAMIC DELIVERY |
4 | 0.0000083785 | PARTNERS AIDS//HIV PATHOGENESIS PROGRAMME//DORIS DUKE MED |
5 | 0.0000080247 | IDIOTYPE//IDIOTYPE VACCINATION//CELL THER Y AREA |
6 | 0.0000067341 | PLASMID PURIFICATION//SUPERCOILED PLASMID DNA//PLASMID DNA |
7 | 0.0000066483 | SKIN GENE THERAPY//HUMAN CLOTTING FACTOR IX//CLOTTING FACTOR IX |
8 | 0.0000065468 | 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN |
9 | 0.0000063630 | CANC VACCINE DEV PROGRAM//CANC SECT//ONCOANTIGENS |
10 | 0.0000061234 | VACCINE DELIVERY//PLG MICROPARTICLES//ADJUVANT UNIT |